Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for BioMed Research International, enter your email address in the box below.

BioMed Research International
Volume 2014 (2014), Article ID 156010, 14 pages
http://dx.doi.org/10.1155/2014/156010
Research Article

Formulation and Optimization of Polymeric Nanoparticles for Intranasal Delivery of Lorazepam Using Box-Behnken Design: In Vitro and In Vivo Evaluation

Deepak Sharma,1 Dipika Maheshwari,1 Gilphy Philip,1 Ravish Rana,1 Shanu Bhatia,1 Manisha Singh,1 Reema Gabrani,1 Sanjeev K. Sharma,1 Javed Ali,2 Rakesh Kumar Sharma,3 and Shweta Dang1

1Department of Biotechnology, Jaypee Institute of Information Technology, A-10 Sector 62, Noida, Uttar Pradesh 201307, India
2Faculty of Pharmacy, Jamia Hamdard, Hamdard Nagar, New Delhi 110062, India
3Division of CBRN Defense, Institute of Nuclear Medicine and Allied Sciences, Brig SK Mazumdar Marg, Delhi 110054, India

Received 28 February 2014; Revised 28 May 2014; Accepted 2 June 2014; Published 14 July 2014

Academic Editor: Weiguo Dai

Copyright © 2014 Deepak Sharma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Shorvon, E. Perucca, and J. Engel Jr., The Treatment of Epilepsy, Wiley-Blackwell, West Sussex, UK, 3rd edition, 2009.
  2. P. N. Patsalos and B. F. D. Bourgeois, The Epilepsy Prescriber's Guide to Antiepileptic Drugs, Cambridge University Press, New York, NY, USA, 1st edition, 2010.
  3. R. H. Levy, R. H. Mattson, B. S. Meldrum, and E. Perucca, Anti-Epileptic Drugs, Lippincott Williams & Wilkins, New York, NY, USA, 5th edition, 2002.
  4. R. G. Strickley, “Solubilizing excipients in oral and injectable formulations,” Pharmaceutical Research, vol. 21, no. 2, pp. 201–230, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. A. A. Date and M. S. Nagarsenker, “Parenteral microemulsions: an overview,” International Journal of Pharmaceutics, vol. 355, no. 1-2, pp. 19–30, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Medina, A. Salvadó, and A. del Pozo, “Use of ultrasound to prepare lipid emulsions of lorazepam for intravenous injection,” International Journal of Pharmaceutics, vol. 216, no. 1-2, pp. 1–8, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Holvoet, Y. Vander Heyden, and J. Plaizier-Vercammen, “Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use,” Drug Development and Industrial Pharmacy, vol. 31, no. 6, pp. 567–575, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. N. M. Sanghavi, K. B. Choudhari, R. S. Matharu, and L. Viswanathan, “Inclusion complexation of Lorazepam with β-cyclodextrin,” Drug Development and Industrial Pharmacy, vol. 19, no. 6, pp. 701–712, 1993. View at Publisher · View at Google Scholar · View at Scopus
  9. A. A. Kale and V. B. Patravale, “Development and evaluation of lorazepam microemulsions for parenteral delivery,” AAPS PharmSciTech, vol. 9, no. 3, pp. 966–971, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. G. D. Anderson and R. P. Saneto, “Current oral and non-oral routes of antiepileptic drug delivery,” Advanced Drug Delivery Reviews, vol. 64, no. 10, pp. 911–918, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. T. M. Ross, P. M. Martinez, J. C. Renner, R. G. Thorne, L. R. Hanson, and W. H. Frey II, “Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis,” Journal of Neuroimmunology, vol. 151, no. 1-2, pp. 66–77, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Wang, X. Jiang, and W. Lu, “Profiles of methotrexate in blood and CSF following intranasal and intravenous administration to rats,” International Journal of Pharmaceutics, vol. 263, no. 1-2, pp. 1–7, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. S. B. Patil and K. K. Sawant, “Development, optimization and in vitro evaluation of alginate mucoadhesive microspheres of carvedilol for nasal delivery,” Journal of Microencapsulation, vol. 26, no. 5, pp. 432–443, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. K. S. Soppimath, T. M. Aminabhavi, A. R. Kulkarni, and W. E. Rudzinski, “Biodegradable polymeric nanoparticles as drug delivery devices,” Journal of Controlled Release, vol. 70, no. 1-2, pp. 1–20, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. R. K. Prajapati, H. S. Mahajan, and S. J. Surana, “PLGA based mucoadhesive microspheres for nasal delivery: in vitro/ex vivo studies,” Indian Journal of Novel Drug Delivery, vol. 3, pp. 9–16, 2011. View at Google Scholar
  16. O. Kammona, A. H. Alexopoulos, P. Karakosta, K. Kotti, V. Karageorgiou, and C. Kiparissides, “Nanocarrier aided nasal vaccination: an experimental and computational approach,” Industrial & Engineering Chemistry Research, vol. 50, no. 2, pp. 590–601, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Dinarvand, N. Sepehri, S. Manoochehri, H. Rouhani, and F. Atyabi, “Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents,” International Journal of Nanomedicine, vol. 6, pp. 877–895, 2011. View at Google Scholar · View at Scopus
  18. F. Danhier, E. Ansorena, J. M. Silva, R. Coco, A. le Breton, and V. Préat, “PLGA-based nanoparticles: an overview of biomedical applications,” Journal of Controlled Release, vol. 161, no. 2, pp. 505–522, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Quintanar-Guerrero, E. Allémann, H. Fessi, and E. Doelker, “Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers,” Drug Development and Industrial Pharmacy, vol. 24, no. 12, pp. 1113–1128, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. U. Bilati, E. Allémann, and E. Doelker, “Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles,” European Journal of Pharmaceutical Sciences, vol. 24, no. 1, pp. 67–75, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Betancourt, B. Brown, and L. Brannon-Peppas, “Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation,” Nanomedicine, vol. 2, no. 2, pp. 219–232, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Cheng, B. A. Teply, I. Sherifi et al., “Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery,” Biomaterials, vol. 28, no. 5, pp. 869–876, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Wilhelm, C. Billotey, J. Roger, J. N. Pons, J.-C. Bacri, and F. Gazeau, “Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating,” Biomaterials, vol. 24, no. 6, pp. 1001–1011, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Huang and M. D. Donovan, “Microsphere transport pathways in the rabbit nasal mucosa,” International Journal of Pharmaceutics, vol. 1, pp. 298–309, 1996. View at Google Scholar
  25. L. R. Hanson and W. H. Frey II, “Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease,” BMC Neuroscience, vol. 9, no. 3, article S5, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Talegaonkar and P. R. Mishra, “Intranasal delivery: an approach to bypass the blood brain barrier,” Indian Journal of Pharmacology, vol. 36, no. 3, pp. 140–147, 2004. View at Google Scholar · View at Scopus
  27. J. Nah, Y. Jeong, and J. Koh, “Drug release from nanoparticles of Poly(DL-lactide-co-glycolide),” Korean Journal of Chemical Engineering, vol. 17, no. 2, pp. 230–236, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Ghasemian, A. Vatanara, A. R. Najafabadi, M. R. Rouini, K. Gilani, and M. Darabi, “Preparation, characterization and optimization of sildenafil citrate loaded PLGA nanoparticles by statistical factorial design,” DARU Journal of Pharmaceutical Sciences, vol. 21, article 68, 2013. View at Google Scholar
  29. J. Hao, X. Fang, Y. Zhou et al., “Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design,” International Journal of Nanomedicine, vol. 6, pp. 683–692, 2011. View at Google Scholar · View at Scopus
  30. C. M. Noronha, A. F. Granada, S. M. de Carvalho, R. C. Lino, M. V. D. O. B. Maciel, and P. L. M. Barreto, “Optimization of α-tocopherol loaded nanocapsules by the nanoprecipitation method,” Industrial Crops and Products, vol. 50, pp. 896–903, 2013. View at Publisher · View at Google Scholar
  31. M. Yasir and U. V. S. Sara, “Preparation and optimization of haloperidol loaded solid lipid nanoparticles by Box-Behnken design,” Journal of Pharmacy Research, vol. 7, no. 6, pp. 551–558, 2013. View at Publisher · View at Google Scholar
  32. G. Sharma, A. K. Mishra, P. Mishra, and A. Misra, “Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies,” AAPS PharmSciTech, vol. 10, no. 4, pp. 1321–1330, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Chigumbu, S. Iyuke, V. Pillay, and S. Ndlovu, “In vitro evaluation of the physicochemical effects of drug loaded carbon nanotubes on toxicity,” Journal of Nanomedicine and Nanotechnology, vol. 3, no. 4, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. A. P. Ranjan, A. Mukerjee, L. Helson, and J. K. Vishwanatha, “Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy,” Journal of Nanobiotechnology, vol. 10, article 38, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. A. R. Pérez, E. G. García, A. Z. Mancera et al., “Designing and evaluation of sodium selenite nanoparticles in vitro to improve selenium absorption in ruminants,” Veterinary Research Communications, vol. 34, no. 1, pp. 71–79, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Jain, A. Mittal, A. K. Jain, R. R. Mahajan, and D. Singh, “Cyclosporin a loaded PLGA nanoparticle: preparation, optimization, in-Vitro characterization and stability studies,” Current Nanoscience, vol. 6, no. 4, pp. 422–431, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Manoochehri, B. Darvishi, G. Kamalinia et al., “Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel,” DARU, Journal of Pharmaceutical Sciences, vol. 21, article 58, no. 1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. R. R. Pillai, S. N. Somayaji, M. Rabinovich, M. C. Hudson, and K. E. Gonsalves, “Nafcillin-loaded PLGA nanoparticles for treatment of osteomyelitis,” Biomedical Materials, vol. 3, no. 3, Article ID 034114, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. G. du, Y. Gao, S. Nie, and W. Pan, “The permeation of nalmefene hydrochloride across different regions of ovine nasal mucosa,” Chemical and Pharmaceutical Bulletin, vol. 54, no. 12, pp. 1722–1724, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. R. K. Averineni, G. V. Shavi, A. K. Gurram et al., “PLGA 50:50 nanoparticles of paclitaxel: development, in vitro anti-tumor activity in BT-549 cells and in vivo evaluation,” Bulletin of Materials Science, vol. 35, no. 3, pp. 319–326, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Budhian, S. J. Siegel, and K. I. Winey, “Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content,” International Journal of Pharmaceutics, vol. 336, no. 2, pp. 367–375, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Feczkó, J. Tóth, G. Dósa, and J. Gyenis, “Influence of process conditions on the mean size of PLGA nanoparticles,” Chemical Engineering and Processing: Process Intensification, vol. 50, no. 8, pp. 846–853, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. R. M. Mainardes and R. C. Evangelista, “PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution,” International Journal of Pharmaceutics, vol. 290, no. 1-2, pp. 137–144, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. U. Seju, A. Kumar, and K. K. Sawant, “Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies,” Acta Biomaterialia, vol. 7, no. 12, pp. 4169–4176, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. S. A. Joshi, S. S. Chavhan, and K. K. Sawant, “Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 76, no. 2, pp. 189–199, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. X. Song, Y. Zhao, S. Hou et al., “Dual agents loaded PLGA nanoparticles: Systematic study of particle size and drug entrapment efficiency,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 69, no. 2, pp. 445–453, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Musumeci, C. A. Ventura, I. Giannone et al., “PLA/PLGA nanoparticles for sustained release of docetaxel,” International Journal of Pharmaceutics, vol. 325, no. 1-2, pp. 172–179, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Panyam, D. William, A. Dash, D. Leslie-Pelecky, and V. Labhasetwar, “Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles,” Journal of Pharmaceutical Sciences, vol. 93, no. 7, pp. 1804–1814, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Kalimouttou, M. Skiba, P. Bon, P. Dechelotte, P. Arnaud, and M. Lahiani-Skiba, “Sinefungin-PLGA nanoparticles: drug loading, Characterization, in vitro drug release and in vivo studies,” Journal of Nanoscience and Nanotechnology, vol. 9, no. 1, pp. 150–158, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. R. M. Mainardes, M. P. D. Gremião, and R. C. Evangelista, “Thermoanalytical study of praziquantel-loaded PLGA nanoparticles,” Brazilian Journal of Pharmaceutical Sciences, vol. 42, no. 4, pp. 523–530, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. B. Sylaja and S. Srinivasan, “Experimental and theoretical investigation of spectroscopic properties of diazepam,” International Journal of ChemTech Research, vol. 4, no. 1, pp. 361–376, 2012. View at Google Scholar · View at Scopus
  52. Y. Ma, Y. Zheng, K. Liu et al., “Nanoparticles of poly(Lactide-Co-Glycolide)-d-a-Tocopheryl polyethylene glycol 1000 succinate random copolymer for cancer treatment,” Nanoscale Research Letters, vol. 5, no. 7, pp. 1161–1169, 2010. View at Publisher · View at Google Scholar · View at Scopus